Company research / BTAI
BioXcel Therapeutics, Inc. (BTAI)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, BioXcel Therapeutics, Inc. reported revenue of $642.0K. Revenue fell 71.7% from the prior annual period.
Key ratios (year ended 2025-12-31)
-7860.0%
Operating margin
-10887.4%
Net margin
-71.7%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.